Evidence map›Paper›PMID 28566588›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Limited Identification of Dual-time-point Positron Emission Tomography/Computed Tomography in Advanced Colorectal Neoplasms.

Kazuhiro Kashiwagi, Yoshihiro Nakazato, Mari Arai, Eisuke Iwasaki, Makoto Naganuma, Nagamu Inoue, Yasushi Iwao, Haruhiko Ogata, Koji Murakami, Takanori Kanai

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Dual-Time-PointBMC cancer · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kazuhiro KashiwagiCenter for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Japan.
Yoshihiro NakazatoCenter for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Japan.
Mari AraiDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University, Japan.
Eisuke IwasakiDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University, Japan.
Makoto NaganumaDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University, Japan.
Nagamu InoueCenter for Preventive Medicine, School of Medicine, Keio University, Japan.
Yasushi IwaoCenter for Preventive Medicine, School of Medicine, Keio University, Japan.
Haruhiko OgataCenter for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Japan.
Koji MurakamiDepartment of Radiology, School of Medicine, Keio University, Japan.
Takanori KanaiDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University, Japan.
Keio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective We investigated whether dual-time-point 18-Fluorodeoxyglucose (

Indexed as

AdenomaAdultAgedAged, 80 and overColonoscopyColorectal NeoplasmsFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedMultimodal ImagingPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticalsadvanced colorectal neoplasmscolonoscopydual-time-point PET/CT

Identifiers

PMID28566588
PMCPMC5498189
OpenAlexW2617371349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.